Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 4, 2023

Primary Completion Date

October 26, 2023

Study Completion Date

October 26, 2023

Conditions
Lentigo SolarSenile Lentigo
Interventions
DEVICE

Prototypes (816-v1 301) to (816-v1 355) every week

Application on brown spots located on the face (6 treatments during the study). An operator previously trained by the dermatologist will apply the study device to the patient's face. Subjects will be lying down, and the prototypes will be administered upside down. During applications, subjects will wear diving goggles protecting the eyes from cryogenic gas.

DEVICE

Prototypes (816-v1 301) to (816-v1 355) every two weeks

Application on brown spots located on the face (6 treatments during the study). An operator previously trained by the dermatologist will apply the study device to the patient's face. Subjects will be lying down, and the prototypes will be administered upside down. During applications, subjects will wear diving goggles protecting the eyes from cryogenic gas.

Trial Locations (1)

Unknown

"Ltd Health", Batumi

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Dermatech

INDUSTRY

collaborator

CEISO

INDUSTRY

collaborator

LTD HEALTH

UNKNOWN

lead

Cryonove Pharma

INDUSTRY

NCT05793619 - Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots | Biotech Hunter | Biotech Hunter